Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingliu He

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|June 7, 2024
Blood cell indices and inflammation-related markers with kidney cancer risk: a large-population prospective analysis in UK BiobankQingliu He, Chengcheng Wei, Li Cao, et al.
Frontiers in Endocrinology|May 15, 2024
Diabetes mellitus, systemic inflammation and overactive bladderQingliu He, Lizhen Wu, Changqi Deng, et al.
Biochemical Pharmacology|June 25, 2026
Loganin triggers ferroptosis in renal cell carcinoma by targeting the IGF2BP2/HMOX1 axis in an m6A-dependent mannerFangzhen Cai, Zhenliang Pan, Haichao Lin, et al.
Scientific Reports|October 25, 2024
Author Correction: Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancerWeihui Liu, Chengcheng Wei, Qingliu He, et al.
Scientific Reports|August 16, 2024
Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancerWeihui Liu, Chengcheng Wei, Qingliu He, et al.
Heliyon|April 5, 2024
Construction of an alignment diagram model for predicting calculous obstructive pyonephrosis before PNLWeihui Liu, Changjin Liu, Wei Zhuang, et al.
Cell Biology and Toxicology|December 27, 2024
RBM19 promotes the progression of prostate cancer under docetaxel treatment via SNHG21/PIM1 axisWei Zhuang, Siwei Xu, Qingliu He, et al.
Cell Death Discovery|April 30, 2026
RBM14 drives prostate cancer metastasis via stabilizing HK2 mRNA to activate glycolysis and H3K18 lactylationZhenhong Liu, Haixin Guo, Zhijiao You, et al.
Cell Death Discovery|May 5, 2026
Correction: NCOA7 inhibits renal cancer progression by inducing autophagy and lipid metabolism through V-ATPase interactionJianjun Wang, Huiwen Luo, Qingliu He, et al.
Cell Death Discovery|October 21, 2025
NCOA7 inhibits renal cancer progression by inducing autophagy and lipid metabolism through V-ATPase interactionJianjun Wang, Huiwen Luo, Qingliu He, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|June 7, 2024
Blood cell indices and inflammation-related markers with kidney cancer risk: a large-population prospective analysis in UK BiobankQingliu He, Chengcheng Wei, Li Cao, et al.
Frontiers in Endocrinology|May 15, 2024
Diabetes mellitus, systemic inflammation and overactive bladderQingliu He, Lizhen Wu, Changqi Deng, et al.
Biochemical Pharmacology|June 25, 2026
Loganin triggers ferroptosis in renal cell carcinoma by targeting the IGF2BP2/HMOX1 axis in an m6A-dependent mannerFangzhen Cai, Zhenliang Pan, Haichao Lin, et al.
Scientific Reports|October 25, 2024
Author Correction: Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancerWeihui Liu, Chengcheng Wei, Qingliu He, et al.
Scientific Reports|August 16, 2024
Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancerWeihui Liu, Chengcheng Wei, Qingliu He, et al.
Heliyon|April 5, 2024
Construction of an alignment diagram model for predicting calculous obstructive pyonephrosis before PNLWeihui Liu, Changjin Liu, Wei Zhuang, et al.
Cell Biology and Toxicology|December 27, 2024
RBM19 promotes the progression of prostate cancer under docetaxel treatment via SNHG21/PIM1 axisWei Zhuang, Siwei Xu, Qingliu He, et al.
Cell Death Discovery|April 30, 2026
RBM14 drives prostate cancer metastasis via stabilizing HK2 mRNA to activate glycolysis and H3K18 lactylationZhenhong Liu, Haixin Guo, Zhijiao You, et al.
Cell Death Discovery|May 5, 2026
Correction: NCOA7 inhibits renal cancer progression by inducing autophagy and lipid metabolism through V-ATPase interactionJianjun Wang, Huiwen Luo, Qingliu He, et al.
Cell Death Discovery|October 21, 2025
NCOA7 inhibits renal cancer progression by inducing autophagy and lipid metabolism through V-ATPase interactionJianjun Wang, Huiwen Luo, Qingliu He, et al.
Pageof 4